Orexo has developed from being an R&D stage company to becoming a profitable fully integrated specialty pharmaceutical company with its own commercial business in the US. From a strong operational and financial platform, Orexo is aiming to become a leader in the field of opioid addiction. To achieve this, the commercial business will be broadened through M&A and proprietary products at the same time as profitability will grow.
